Entrada Therapeutics Inc 2025年季度报告

(Mark One)xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACTOF 1934 For the quarterly period endedMarch31, 2025or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACTOF 1934 For the transition period from ____________ to ____________Commission File Number:001-40969____________________________ ENTRADA THERAPEUTICS, INC. (Exact name of registrant as specified in its charter)____________________________ Registrant’s telephone number, including area code: (857)520-9158 Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during thepreceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90days.YesxNoo Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).YesxNoo Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerginggrowth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of theExchange Act. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revisedfinancial accounting standards provided pursuant to Section 13(a) of the Exchange Act.o As of April30, 2025, the registrant had37,953,417shares of common stock, $0.0001 par value per share, outstanding. TABLE OF CONTENTS Part IFinancial InformationItem 1.Financial Statements (Unaudited)8Condensed Consolidated Balance Sheets8Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)9CondensedConsolidatedStatements of Stockholders’ Equity10Condensed Consolidated Statements of Cash Flows11Notes to Condensed Consolidated Financial Statements12Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations23Item 3.Quantitative and Qualitative Disclosures about Market Risk32Item 4.Controls and Procedures33Part IIOther InformationItem 1.Legal Proceedings34Item 1A.Risk Factors34Item 2.Unregistered Sales of Equity Securities,Use of Proceeds, and Issuer Purchases of Equity96Item 3.Defaults Upon Senior Securities96Item 4.Mine Safety Disclosures96Item 5.Other Information96Item 6.Exhibits98Signatures99 We own various U.S. federal trademark applications and unregistered trademarks, including our company name and logo, thatwe use in connection with the operation of our business. This Quarterly Report on Form 10-Q ("Quarterly Report") may also containtrademarks, service marks and trade names of third parties, which are the property of their respective owners. Our use or display ofthird parties’ trademarks, service marks, trade names or products in this Quarterly Report is not intended to, and does not imply arelationship with, or endorsement or sponsorship by us. Solely for convenience, the trademarks, service marks and trade namesreferred to in this Quarterly Report may appear without the ®, TM or SM symbols, but the omission of such references is not intendedto indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or that the applicable owner ofthese trademarks, service marks and trade names will not assert, to the fullest extent under applicable law, its rights. From time to time, we may use our website or our LinkedIn profile at www.linkedin.com/company/entradatx to distributematerial information. Our financial and other material information is routinely posted to and accessible on the Investors Relationssection of our website, available at www.entradatx.com. Investors are encouraged to review the Investors Relations section of ourwebsite because we may post material information on that site that is not otherwise disseminated by us. Information that is containedin and can be accessed through our website or our LinkedIn profile is not incorporated into, and does not form a part of, this QuarterlyReport. CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSThis Quarterly Report on Form 10-Q (“Quarterly Report”)contains express or implied forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the“Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements arebased on our management’s current beliefs, expectations and